Literature DB >> 18154361

Binding mechanisms of PEGylated ligands reveal multiple effects of the PEG scaffold.

Raibatak Das1, Emily Baird, Scott Allen, Barbara Baird, David Holowka, Byron Goldstein.   

Abstract

A series of synthetic ligands consisting of poly(ethylene glycol) (PEG), capped on one or both ends with the hapten 2,4-dinitrophenyl (DNP), were previously shown to be potent inhibitors of cellular activation in RBL mast cells stimulated by a multivalent antigen [Baird, E. J., Holowka, D., Coates, G. W., and Baird, B. (2003) Biochemistry 42, 12739-12748]. In this study, we systematically investigated the effect of increasing length of the PEG scaffold on the binding of these monovalent and bivalent ligands to anti-DNP IgE in solution. Our analysis reveals evidence for an energetically favorable interaction between two monovalent ligands bound to the same receptor, when the PEG molecular mass exceeds approximately 5 kDa. Additionally, for ligands with much higher molecular masses (>10 kDa PEG), the binding of a single ligand apparently leads to a steric exclusion of the second binding site by the bulky PEG scaffold. These results are further corroborated by data from an alternate fluorescence-based assay that we developed to quantify the capacity of these ligands to displace a small hapten bound to IgE. This new assay monitors the displacement of a small, receptor-bound hapten by a competitive monovalent ligand and thus quantifies the competitive inhibition offered by a monovalent ligand. We also show that, for bivalent ligands, inhibitory capacity is correlated with the capacity to form effective intramolecular cross-links with IgE.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18154361     DOI: 10.1021/bi702094j

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  7 in total

1.  Dependence of avidity on linker length for a bivalent ligand-bivalent receptor model system.

Authors:  Eric T Mack; Phillip W Snyder; Raquel Perez-Castillejos; Başar Bilgiçer; Demetri T Moustakas; Manish J Butte; George M Whitesides
Journal:  J Am Chem Soc       Date:  2011-12-21       Impact factor: 15.419

2.  Conformational and aggregation properties of a PEGylated alanine-rich polypeptide.

Authors:  Ayben Top; Christopher J Roberts; Kristi L Kiick
Journal:  Biomacromolecules       Date:  2011-05-09       Impact factor: 6.988

3.  Cellular responses to patterned poly(acrylic acid) brushes.

Authors:  Ethan N Chiang; Rong Dong; Christopher K Ober; Barbara A Baird
Journal:  Langmuir       Date:  2011-05-10       Impact factor: 3.882

4.  Nanoparticle-mediated IgE-receptor aggregation and signaling in RBL mast cells.

Authors:  Yu-Fen Huang; Haipeng Liu; Xiangling Xiong; Yan Chen; Weihong Tan
Journal:  J Am Chem Soc       Date:  2009-12-02       Impact factor: 15.419

5.  Clustering and internalization of integrin alphavbeta3 with a tetrameric RGD-synthetic peptide.

Authors:  Lucie Sancey; Sancey Lucie; Elisabeth Garanger; Garanger Elisabeth; Stéphanie Foillard; Foillard Stéphanie; Guy Schoehn; Schoehn Guy; Amandine Hurbin; Hurbin Amandine; Corinne Albiges-Rizo; Albiges-Rizo Corinne; Didier Boturyn; Boturyn Didier; Catherine Souchier; Souchier Catherine; Alexeï Grichine; Grichine Alexeï; Pascal Dumy; Dumy Pascal; Jean-Luc Coll; Coll Jean-Luc
Journal:  Mol Ther       Date:  2009-03-03       Impact factor: 11.454

6.  Mapping the binding site topology of amyloid protein aggregates using multivalent ligands.

Authors:  Elena Sanna; Margarida Rodrigues; Steven G Fagan; Timothy S Chisholm; Klara Kulenkampff; David Klenerman; Maria Grazia Spillantini; Franklin I Aigbirhio; Christopher A Hunter
Journal:  Chem Sci       Date:  2021-06-07       Impact factor: 9.825

7.  Dextran as a generally applicable multivalent scaffold for improving immunoglobulin-binding affinities of peptide and peptidomimetic ligands.

Authors:  Jumpei Morimoto; Mohosin Sarkar; Sophia Kenrick; Thomas Kodadek
Journal:  Bioconjug Chem       Date:  2014-07-30       Impact factor: 4.774

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.